Phase II Study Of The Hyper-CVAD Regimen In Combination With Ofatumumab As Frontline Therapy For Adults With CD-20 Positive Acute Lymphoblastic Leukemia (ALL)
暂无分享,去创建一个
H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | T. Kadia | F. Ravandi | E. Jabbour | S. O'brien | K. Sasaki | D. Thomas | Rebecca E. Garris